Multifaceted Physiological Roles of Lipoproteins and Understanding Atherosclerosis: Crosstalk Between Lipoproteins and Bioactive Lipids
Abstract
Traditional management of atherosclerosis focuses primarily on cholesterol and triglycerides; however, lipoproteins also transport bioactive lipids that critically regulate systemic inflammation and metabolic health. This review highlights the diverse physiological and clinical roles of apolipoproteins and bioactive lipids beyond classical lipid accumulation. First, we discuss how hepatic transporters NPC1L1 and ABCG5/8 modulate glucose metabolism and handle non-cholesterol lipids, including phytosterols. Second, we emphasize the apolipoprotein M (ApoM) and sphingosine 1-phosphate (S1P) axis. ApoM protects S1P from degradation and directly mediates the pleiotropic benefits of high-density lipoprotein (HDL), including anti-apoptotic, antithrombotic, and renoprotective effects. Third, reverse translational research utilizing genome-wide association studies identifies apolipoprotein D (ApoD) as a key anti-inflammatory modulator. Finally, clinical lipidomics underscores the importance of “minor” lysophospholipids, such as lysophosphatidylinositol and lysophosphatidylserine, alongside lysophosphatidic acid in the pathogenesis of acute coronary syndrome. Understanding the dynamic crosstalk between lipid transporters, apolipoproteins, and bioactive lipids provides novel mechanistic insights into cardiovascular and metabolic diseases, paving the way for innovative biomarkers and precision therapeutic strategies.
Related
- Transendothelial Transport of Low-Density Lipoproteins in Atherosclerosis: Mechanisms of Activation and Possible Therapeutic Targets
- HDL – Immune Cell Crosstalk in Autoimmune Diseases and its Role in Accelerated Atherosclerosis
- ATP Inside and Out: Understanding Atherosclerosis Through Energy Metabolism and Purinergic Signaling
- Remnant Lipoproteins as Dynamic Metabolic States: A Residence Time–Based Framework for TRL Metabolism
- A Chemokine Profile Linked to Both Triglyceride-Rich Lipoproteins and Lipoprotein(a), But Not LDL, Is Associated With Cardiovascular Disease.
BibTeX
@article{kurano2026multifaceted,
title = {{Multifaceted Physiological Roles of Lipoproteins and Understanding Atherosclerosis: Crosstalk Between Lipoproteins and Bioactive Lipids}},
author = {Makoto Kurano},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
month = oct,
doi = {10.5551/jat.rv22062},
url = {https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_RV22062/_article},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Multifaceted Physiological Roles of Lipoproteins and Understanding Atherosclerosis: Crosstalk Between Lipoproteins and Bioactive Lipids
AU - Makoto Kurano
PY - 2026
DA - 2026/10/28
JO - Journal of Atherosclerosis and Thrombosis
DO - 10.5551/jat.rv22062
UR - https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_RV22062/_article
AB - Traditional management of atherosclerosis focuses primarily on cholesterol and triglycerides; however, lipoproteins also transport bioactive lipids that critically regulate systemic inflammation and metabolic health. This review highlights the diverse physiological and clinical roles of apolipoproteins and bioactive lipids beyond classical lipid accumulation. First, we discuss how hepatic transporters NPC1L1 and ABCG5/8 modulate glucose metabolism and handle non-cholesterol lipids, including phytosterols. Second, we emphasize the apolipoprotein M (ApoM) and sphingosine 1-phosphate (S1P) axis. ApoM protects S1P from degradation and directly mediates the pleiotropic benefits of high-density lipoprotein (HDL), including anti-apoptotic, antithrombotic, and renoprotective effects. Third, reverse translational research utilizing genome-wide association studies identifies apolipoprotein D (ApoD) as a key anti-inflammatory modulator. Finally, clinical lipidomics underscores the importance of “minor” lysophospholipids, such as lysophosphatidylinositol and lysophosphatidylserine, alongside lysophosphatidic acid in the pathogenesis of acute coronary syndrome. Understanding the dynamic crosstalk between lipid transporters, apolipoproteins, and bioactive lipids provides novel mechanistic insights into cardiovascular and metabolic diseases, paving the way for innovative biomarkers and precision therapeutic strategies.
SN - 1880-3873
SN - 1340-3478
ER -